{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:34:56Z","timestamp":1767990896819,"version":"3.49.0"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1001\/jamadermatol.2021.2474","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T15:33:58Z","timestamp":1627486438000},"page":"1128","source":"Crossref","is-referenced-by-count":19,"title":["Association of Facial Pustular Neutrophilic Eruption With Messenger RNA\u20131273 SARS-CoV-2 Vaccine"],"prefix":"10.1001","volume":"157","author":[{"given":"Eric Dean","family":"Merrill","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakeen W.","family":"Kashem","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin H.","family":"Amerson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"},{"name":"Department of Dermatology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura B.","family":"Pincus","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"},{"name":"Dermatopathology Service, Departments of Dermatology and Pathology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula E.","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"},{"name":"Department of Dermatology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"},{"name":"Dermatopathology Service, Departments of Dermatology and Pathology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanade","family":"Shinkai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"},{"name":"Department of Dermatology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"dlo210012r1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"dlo210012r3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases.","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"dlo210012r4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2.","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"dlo210012r5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40257-017-0310-0","article-title":"Diagnosis and treatment of rosacea fulminans: a comprehensive review.","volume":"19","author":"Walsh","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"dlo210012r2","unstructured":"US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee meeting December 17, 2020. Accessed March 18, 2021. https:\/\/www.fda.gov\/media\/144434\/download"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2782441\/jamadermatology_merrill_2021_lo_210012_1631232154.03749.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T15:30:34Z","timestamp":1631719834000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2782441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.2474","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}